A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Abbott's Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy for people who need alternatives to traditional treatment approaches; about 50% of adults with diabetes will develop peripheral neuropathy
Published: January 26, 2023 by Abbott Laboratories
AGC Biologics tapped to produce long-awaited diabetes drug
Published: January 25, 2023 by FiercePharma
HHS report finds Inflation Reduction Act’s US$35 cap on month’s supply of insulin would have saved people with Medicare about US$500 on their insulin costs in 2020; the Act’s insulin provision went into effect January 1, 2023 for Medicare Part D
Published: January 25, 2023 by U.S. Dept. of Health and Human Services (HHS)
AGC Biologics to Commercial Manufacture Provention Bio Diabetes Therapy
Published: January 25, 2023 by Contify Life Science News
AGC Biologics Supports Commercial Production of Provention Bio’s New Type 1 Diabetes (T1D) Therapy, TZIELD™
Published: January 25, 2023 by Eastern Herald, The (India)

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count